Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes the corona virus disease-19 which is accompanied by severe pneumonia, pulmonary alveolar collapses and which stops oxygen exchange. Viral transmissibility and pathogenesis depend on recognition by a receptor in the host, protease cl...

Full description

Bibliographic Details
Main Authors: María Elena Soto, Verónica Guarner-Lans, Elizabeth Soria-Castro, Linaloe Manzano Pech, Israel Pérez-Torres
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1010-660X/56/8/386
_version_ 1797728630847045632
author María Elena Soto
Verónica Guarner-Lans
Elizabeth Soria-Castro
Linaloe Manzano Pech
Israel Pérez-Torres
author_facet María Elena Soto
Verónica Guarner-Lans
Elizabeth Soria-Castro
Linaloe Manzano Pech
Israel Pérez-Torres
author_sort María Elena Soto
collection DOAJ
description Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes the corona virus disease-19 which is accompanied by severe pneumonia, pulmonary alveolar collapses and which stops oxygen exchange. Viral transmissibility and pathogenesis depend on recognition by a receptor in the host, protease cleavage of the host membrane and fusion. SARS-CoV-2 binds to the angiotensin converting enzyme 2 receptor. Here, we discuss the general characteristics of the virus, its mechanism of action and the way in which the mechanism correlates with the comorbidities that increase the death rate. We also discuss the currently proposed therapeutic measures and propose the use of antioxidant drugs to help patients infected with the SARS-CoV-2. Oxidizing agents come from phagocytic leukocytes such as neutrophils, monocytes, macrophages and eosinophils that invade tissue. Free radicals promote cytotoxicity thus injuring cells. They also trigger the mechanism of inflammation by mediating the activation of NFkB and inducing the transcription of cytokine production genes. Release of cytokines enhances the inflammatory response. Oxidative stress is elevated during critical illnesses and contributes to organ failure. In corona virus disease-19 there is an intense inflammatory response known as a cytokine storm that could be mediated by oxidative stress. Although antioxidant therapy has not been tested in corona virus disease-19, the consequences of antioxidant therapy in sepsis, acute respiratory distress syndrome and acute lung injury are known. It improves oxygenation rates, glutathione levels and strengthens the immune response. It reduces mechanical ventilation time, the length of stay in the intensive care unit, multiple organ dysfunctions and the length of stay in the hospital and mortality rates in acute lung injury/acute respiratory distress syndrome and could thus help patients with corona virus disease-19.
first_indexed 2024-03-12T11:16:53Z
format Article
id doaj.art-9101bc171f5a4bb2b6904809925cc677
institution Directory Open Access Journal
issn 1010-660X
language English
last_indexed 2024-03-12T11:16:53Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-9101bc171f5a4bb2b6904809925cc6772023-09-02T01:54:59ZengMDPI AGMedicina1010-660X2020-07-015638638610.3390/medicina56080386Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its ApplicationMaría Elena Soto0Verónica Guarner-Lans1Elizabeth Soria-Castro2Linaloe Manzano Pech3Israel Pérez-Torres4Immunology Department, Instituto Nacional de Cardiología “Ignacio Chávez”, Juan Badiano 1, Sección XVI, Tlalpan, México City 14080, MexicoPhysiology Department, Instituto Nacional de Cardiología “Ignacio Chávez”, Juan Badiano 1, Sección XVI, Tlalpan, México City 14080, MexicoVascular Biomedicine Department, Instituto Nacional de Cardiología “Ignacio Chávez”, Juan Badiano 1, Sección XVI, Tlalpan, México City 14080, MexicoVascular Biomedicine Department, Instituto Nacional de Cardiología “Ignacio Chávez”, Juan Badiano 1, Sección XVI, Tlalpan, México City 14080, MexicoVascular Biomedicine Department, Instituto Nacional de Cardiología “Ignacio Chávez”, Juan Badiano 1, Sección XVI, Tlalpan, México City 14080, MexicoSevere Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) causes the corona virus disease-19 which is accompanied by severe pneumonia, pulmonary alveolar collapses and which stops oxygen exchange. Viral transmissibility and pathogenesis depend on recognition by a receptor in the host, protease cleavage of the host membrane and fusion. SARS-CoV-2 binds to the angiotensin converting enzyme 2 receptor. Here, we discuss the general characteristics of the virus, its mechanism of action and the way in which the mechanism correlates with the comorbidities that increase the death rate. We also discuss the currently proposed therapeutic measures and propose the use of antioxidant drugs to help patients infected with the SARS-CoV-2. Oxidizing agents come from phagocytic leukocytes such as neutrophils, monocytes, macrophages and eosinophils that invade tissue. Free radicals promote cytotoxicity thus injuring cells. They also trigger the mechanism of inflammation by mediating the activation of NFkB and inducing the transcription of cytokine production genes. Release of cytokines enhances the inflammatory response. Oxidative stress is elevated during critical illnesses and contributes to organ failure. In corona virus disease-19 there is an intense inflammatory response known as a cytokine storm that could be mediated by oxidative stress. Although antioxidant therapy has not been tested in corona virus disease-19, the consequences of antioxidant therapy in sepsis, acute respiratory distress syndrome and acute lung injury are known. It improves oxygenation rates, glutathione levels and strengthens the immune response. It reduces mechanical ventilation time, the length of stay in the intensive care unit, multiple organ dysfunctions and the length of stay in the hospital and mortality rates in acute lung injury/acute respiratory distress syndrome and could thus help patients with corona virus disease-19.https://www.mdpi.com/1010-660X/56/8/386COVID-19antioxidant therapyACE2 receptorsepsisSARS-CoV-2
spellingShingle María Elena Soto
Verónica Guarner-Lans
Elizabeth Soria-Castro
Linaloe Manzano Pech
Israel Pérez-Torres
Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application
Medicina
COVID-19
antioxidant therapy
ACE2 receptor
sepsis
SARS-CoV-2
title Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application
title_full Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application
title_fullStr Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application
title_full_unstemmed Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application
title_short Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application
title_sort is antioxidant therapy a useful complementary measure for covid 19 treatment an algorithm for its application
topic COVID-19
antioxidant therapy
ACE2 receptor
sepsis
SARS-CoV-2
url https://www.mdpi.com/1010-660X/56/8/386
work_keys_str_mv AT mariaelenasoto isantioxidanttherapyausefulcomplementarymeasureforcovid19treatmentanalgorithmforitsapplication
AT veronicaguarnerlans isantioxidanttherapyausefulcomplementarymeasureforcovid19treatmentanalgorithmforitsapplication
AT elizabethsoriacastro isantioxidanttherapyausefulcomplementarymeasureforcovid19treatmentanalgorithmforitsapplication
AT linaloemanzanopech isantioxidanttherapyausefulcomplementarymeasureforcovid19treatmentanalgorithmforitsapplication
AT israelpereztorres isantioxidanttherapyausefulcomplementarymeasureforcovid19treatmentanalgorithmforitsapplication